Literature DB >> 15317151

The biology and pharmacology of calcium channel alpha2-delta proteins Pfizer Satellite Symposium to the 2003 Society for Neuroscience Meeting. Sheraton New Orleans Hotel, New Orleans, LA November 10, 2003.

Charles P Taylor.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15317151      PMCID： PMC6494135          DOI： 10.1111/j.1527-3458.2004.tb00012.x

Source DB:  PubMed          Journal:  CNS Drug Rev        ISSN： 1080-563X


× No keyword cloud information.
  21 in total

1.  New Horizons in the development of antiepileptic drugs: Innovative strategies.

Authors:  Wolfgang Löscher; Dieter Schmidt
Journal:  Epilepsy Res       Date:  2006-06       Impact factor: 3.045

Review 2.  Pregabalin: in the treatment of postherpetic neuralgia.

Authors:  James E Frampton; Rachel H Foster
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Retrospective chart review of duloxetine and pregabalin in the treatment of painful neuropathy.

Authors:  Manoj Mittal; Mamatha Pasnoor; Reddiah B Mummaneni; Saud Khan; April McVey; David Saperstein; Laura Herbelin; Larry Ridings; Yunxia Wang; Mazen M Dimachkie; Richard J Barohn
Journal:  Int J Neurosci       Date:  2011-06-15       Impact factor: 2.292

4.  Pregabalin abuse and dependence in Germany: results from a database query.

Authors:  Maximilian Gahr; Roland W Freudenmann; Christoph Hiemke; Makus A Kölle; Carlos Schönfeldt-Lecuona
Journal:  Eur J Clin Pharmacol       Date:  2013-01-05       Impact factor: 2.953

5.  A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.

Authors:  T G Tzellos; G Papazisis; K A Toulis; Ch Sardeli; D Kouvelas
Journal:  Hippokratia       Date:  2010-04       Impact factor: 0.471

6.  Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society.

Authors:  D E Moulin; A J Clark; I Gilron; M A Ware; C P N Watson; B J Sessle; T Coderre; P K Morley-Forster; J Stinson; A Boulanger; P Peng; G A Finley; P Taenzer; P Squire; D Dion; A Cholkan; A Gilani; A Gordon; J Henry; R Jovey; M Lynch; A Mailis-Gagnon; A Panju; G B Rollman; A Velly
Journal:  Pain Res Manag       Date:  2007       Impact factor: 3.037

7.  Systemic pregabalin attenuates sensorimotor responses and medullary glutamate release in inflammatory tooth pain model.

Authors:  N Narita; N Kumar; P S Cherkas; C Y Chiang; J O Dostrovsky; T J Coderre; B J Sessle
Journal:  Neuroscience       Date:  2012-05-17       Impact factor: 3.590

Review 8.  Pregabalin: in the treatment of painful diabetic peripheral neuropathy.

Authors:  James E Frampton; Lesley J Scott
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Authors:  Latika Puri; Kerri A Nottage; Jane S Hankins; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

Review 10.  Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature.

Authors:  Thrasivoulos G Tzellos; Georgios Papazisis; Ekaterini Amaniti; Dimitrios Kouvelas
Journal:  Eur J Clin Pharmacol       Date:  2008-07-08       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.